Glucagonlike peptide-1 (GLP-1) agonist medications can help treat several medical conditions and improve heart and kidney health. There are several FDA-approved GLP-1 agonists, including: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (M...
Recent coverage curated from local and regional sources.
WASHINGTON, July 23, 2026: On June 9th, the U.S. State Department published on the Federal Register an update to its schedule of fees for pr…
The connection between Johnson and her alleged victim, along with a potential motive, remains unclear.
EL PASO, Texas (KVIA) -- We are under an ABC-7 First Alert because of our climbing temperatures. We are anticipating the return of dangerous…
U.S. Secret Service Director Sean Curran on Wednesday said the agency has opened more than 10,000 investigations this year into threats agai…
By Tierney Sneed, CNN (CNN) — A little-known court tasked with handling highly sensitive deportation cases against alleged alien terrorists …
By Nathaniel Meyersohn, CNN New York (CNN) — I knew when I emailed the Equinox manager complaining about the hulking, rarely used Nautilus m…
Por Osmary Hernández y Rocío Muñoz-Ledo, CNN en Español La primera noche durmieron en el estacionamiento del Polideportivo José María Vargas…
By Hanna Ziady, CNN London (CNN) — The European Union has fined Google €890 million ($1 billion) for breaching rules designed to promote com…
Por Julianna Bragg, CNN Un hombre murió por disparos durante un forcejeo con agentes de policía en Madison, Wisconsin, después de que, según…
Democrats in a new poll have an 11-point lead over Republicans on a generic congressional ballot as the midterm fight for control of the Hou…
The incident is stirring debates over the need for stronger AI guardrails and the extent to which AI agents are capable of acting on their o…
By Marshall Cohen, Gabe Cohen, CNN Boston (CNN) — Four days after President Donald Trump declared that his administration uncovered “shockin…
Free weekly digest. Local news that actually matters — no spam, no clickbait, easy unsubscribe.
By subscribing you agree to our privacy policy. We never sell your data.